CClinicalTrials.gg
CompletedNCT01025024Updated Dec 3, 2009

Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients

An observational study in Single-nucleotide Polymorphism (SNP) for Glaucoma, sponsored by Chungnam National University. Completed at 1 site in Korea, Republic of. Open to participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-12-03.

Sponsored by Chungnam National University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
1,224
Ages
30 Years and older
Sex
All
01

Study summary

A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.

Read the detailed description

Unrelated Korean subjects who have primary open angle glaucoma were recruited in the current study. Genotyping for various SNP associated with POAG due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with primary open angle glaucoma and normal control subjects free of any eye diseases.

02

Conditions studied

  • Single-nucleotide Polymorphism (SNP) for Glaucoma

Keywords

  • SNP
  • single-nucleotide polymorphism
  • glaucoma
  • primary open angle glaucoma
03

In context

Glaucoma

1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.

This study's enrollment of 1,224 is above the median of 103 across 454 observational studies indexed under Glaucoma.

Browse Glaucoma studies →

Lead sponsor

Chungnam National University is the lead sponsor of 12 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

patients with open angle glaucoma who visited glaocoma clinic of departemtn of Ophtalmology, Chungnam National University Hospital, Daejeon, south Korea

Inclusion criteria

  • Clinical diagnosis of primary open angle glaucoma

Exclusion criteria

Exclusion Criteria:

  • Primary open angle glaucoma combined with congenital ocular disease
  • Primary open angel glaucoma combined with other ocular disease
  • Significant systemic disease other than systemic hypertension and diabetes
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
1,224 participants (actual)
Biospecimen retention
Samples with dna

Groups and cohorts

  • POAG group

    Elevated intraocular pressure normal open angle glaucomatous optic nerve head abnormality glaucomatous visual field defect

    Genetic: SNP analysis of the DNA

  • Normal control

    Normal intraocular pressure No optic disc abnormality No visual field defect No significant ocular and systemic disease

    Genetic: SNP analysis of the DNA

Interventions

  • GeneticSNP analysis of the DNA

    SNP analysis of the DNA obtained from peripheral blood sample

06

What researchers measure

Primary outcomes

  1. genotyping for the SNP associated with primary open angle glaucoma

    Time frame: one year

Secondary outcomes

  1. genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns

    Time frame: one year

07

Study locations

1 site
  • Chungnam National University Hospital
    Daejeon, 301-721, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01025024
Lead sponsor
Chungnam National University
Collaborators
Korea Healthcare Technology R&D Project, Korea Advanced Institute of Science and Technology
First posted
Dec 3, 2009
Start date
Jan 2007
Primary completion
Oct 2009
Completion
Nov 2009
Last update
Dec 3, 2009

Study contacts

Chang-sik Kim, professor
principal investigator · Department of Ophthalmology, Chungnam National University Hospital
Changwon Kang, professor
study chair · Korea Advanced Institute of Science and Technology
Kyunglan Kim
study director · Department of Biological Sciences, Korea Advanced Institute of Science and Technology

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion